September 2, 2020
UC San Diego Health will be part of the Phase III national AstraZeneca clinical trial that will recruit up to 30,000 participants at multiple sites across the country to assess the safety and efficacy of a vaccine to prevent COVID-19.
October 18, 2023
UC San Diego engineers have developed an experimental vaccine that could prevent the spread of metastatic cancers to the lungs. Its success lies in targeting a protein known to play a central role in cancer growth and spread, rather than targeting the primary tumor itself.
November 3, 2022
This season there are three prevalent respiratory viruses to be aware of—influenza, SARS-CoV-2 and respiratory syncytial virus (RSV), all of which are transmitted via aerosols.
April 1, 2021
UC San Diego students will participate in nationwide clinical trial to assess if COVID-19 vaccination prevents infection and reduces risk of transmission.
February 18, 2015
…The method is the newest attempt to develop a vaccine that prevents transmission of the malaria parasite from host to mosquito.
August 5, 2021
Local public health leaders, including Herbert Wertheim School of Public Health and Human Longevity Science at UC San Diego, are calling on parents to protect children from preventable diseases, in particular the human papillomavirus (HPV) which is responsible for 36,000 new cancer diagnosis yearly.
September 16, 2016
In a Perspective piece published this week in PNAS, cancer researchers from across the country, including faculty at University of California San Diego School of Medicine and Moores Cancer Center, write that a greater emphasis on immune-based prevention should be central to new efforts like the federal Cancer Moonshot program,…
October 12, 2018
…at UC San Diego Health to test a personalized vaccine using her unique cancer mutations to boost an anti-tumor immune response.
April 24, 2024
A new study published in JAMA finds that X’s (formerly Twitter’s) Community Notes, a crowdsourced approach to addressing misinformation, helped counter false health information in popular posts about COVID-19 vaccines by providing accurate, credible responses.
April 20, 2020
UC San Diego nanoengineers received a Rapid Response Research (RAPID) grant from the National Science Foundation to develop—using a plant virus—a stable, easy to manufacture COVID-19 vaccine patch that can be shipped around the world and painlessly self-administered by patients.
